Smarter radiation for advanced pancreatic cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a new type of radiation that adapts in real time using MRI scans. It is for people with locally advanced pancreatic cancer that has not spread, and who have already completed at least 4 cycles of chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with pancreatic adenocarcinoma (a type of pancreatic cancer) through a biopsy.
- You must be 18 years or older.
- Your cancer must be locally advanced (has not spread to other parts of the body) based on recent scans.
- You must have had at least 4 cycles of chemotherapy (Folfirinox or Gemzar-Abraxane), but no more than 8 cycles.
- You cannot have had radiation to your belly area before, and you must be able to have an MRI (no metal implants, no severe claustrophobia).
- If you are a woman who can become pregnant, you must have a negative pregnancy test and use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests giving specific chemotherapy in sequence, then using MRI-guided focused radiation to treat locally advanced, non-removable pancreatic cancer. It may help shrink or control the tumor while aiming radiation more precisely using MRI.
This trial tests a new type of MRI-guided radiation therapy for people with locally advanced pancreatic cancer that can't be removed by surgery. If you have already had 2 months of chemotherapy, or chose not to, this treatment might help control the tumor.
This trial tests whether combining targeted radiation with an at-home “tumor treating fields” device can better control locally advanced pancreatic cancer. It may help by attacking cancer cells in more than one way after prior chemotherapy.
This trial tests whether giving a strong, focused dose of radiation can help people with locally advanced pancreatic cancer that has shrunk or stayed stable with first-line chemotherapy. It aims to improve outcomes for those who cannot have surgery.
This trial tests a new treatment called DaRT, which places tiny radioactive devices directly into your pancreatic tumor. It is for people with locally advanced pancreatic cancer that has not spread, after they have already had standard chemotherapy.
This study tests a highly focused radiation plan that uses MRI scans to adjust treatment during therapy. It’s for people with locally advanced pancreatic cancer who have already completed a set course of chemotherapy and whose cancer hasn’t grown.
Hear when a new Locally Advanced Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.